How squalene helps a flu vaccine get noticed
A vaccine has to give the immune system a clear enough signal to prepare for a real infection. In some flu shots, squalene is part of an adjuvant: an ingredient added to strengthen the immune response to the vaccine’s inactivated virus material. The squalene is formulated as tiny droplets mixed with water, rather than poured in as a layer of oil.
Those droplets help create a short-lived, localized immune response at the injection site. Immune cells arrive, take up vaccine material, and carry signals that help coordinate the response. The result can be a stronger antibody response than the inactivated virus material would produce on its own. Scientists continue to study the details of how these emulsions work; it is not simply that squalene acts as a piece of flu virus for the body to recognize.
The oil is an ingredient, not the target
Squalene is a naturally occurring oily substance found in living things, including shark livers. When it is used in a vaccine adjuvant, it is highly processed and combined with other ingredients to make the emulsion. The immune system’s main target remains the flu-virus components in the shot—not the shark and not the oil itself.
That distinction explains the ingredient’s role: the inactivated virus supplies the lesson, while the adjuvant helps make the lesson more noticeable to the immune system. A stronger response can be especially useful when a vaccine needs to prompt protection with less readily stimulating material, though adjuvants are included only in particular vaccine formulations. In other words, the striking origin of the ingredient is less important to its function than the tiny droplets it forms in the finished shot.
